Already available in the UK, EU, US and other countries around the world, AiVF is a leading innovator in fertility technology, which can increase the average number of healthy pregnancies by 30% when embryos are selected through the AiVF program.
"We are delighted to bring our innovative solutions to Australia, marking a significant step forward in our mission to support individuals and couples on their journey to parenthood," said Daniella Gilboa, CEO and co-founder of AIVF, interviewed by Altaroc a few months ago.
AiVF's technology is designed to accelerate time to pregnancy and increase the success rates of predicted clinical pregnancies, through the use of advanced artificial intelligence. The arrival on the Australian market ensures that patients now have access to some of the most sophisticated and proven fertility technologies available.
This result is the fruit of five years of intensive research, during which tens of thousands of embryos were analyzed using state-of-the-art artificial intelligence models and data from five continents.
